PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22085439-1	2011	BACKGROUND: This study evaluated the efficacy and safety of the long-acting beta2-agonist formoterol in patients with moderate-to-severe COPD.	Formoterol Fumarate	90-100	potassium calcium-activated channel subfamily M regulatory beta subunit 2	Homo sapiens	76-81